​

Immunovant (IMVT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Immunovant Revenue Highlights

00

Immunovant Revenue by Period

Immunovant Revenue by Year

DateRevenueChange
2024-03-31-100.00%
2023-03-31-100.00%
2022-03-31-100.00%
2021-03-31-100.00%
2020-03-31-100.00%
2019-03-31-100.00%
2018-12-31--

Immunovant generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Immunovant Revenue by Quarter

DateRevenueChange
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$1.50M100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31$925.80K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--

Immunovant generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Immunovant Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$709.95M$176.57M
BPMCBlueprint Medicines$508.82M$128.18M
LEGNLegend Biotech$285.14M$93.99M
ARQTArcutis Biotherapeutics$196.54M$30.86M
MDGLMadrigal Pharmaceuticals$180.13M$62.17M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
ACLXArcellx$107.94M$26.03M
AMLXAmylyx Pharmaceuticals$87.37M$416.00K
STOKStoke Therapeutics$36.55M$4.89M
ABUSArbutus Biopharma$6.17M$1.73M
ETNB89bio--
AKROAkero Therapeutics--
PTGXProtagonist Therapeutics-$4.67M
IMVTImmunovant--
PLRXPliant Therapeutics--

IMVT Revenue FAQ

What is Immunovant’s yearly revenue?

Immunovant's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. IMVT's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Immunovant’s quarterly revenue?

Immunovant's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). IMVT's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Immunovant’s revenue growth rate?

Immunovant's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.